IXICO (LON:IXI) Share Price Crosses Below 200-Day Moving Average – What’s Next?

IXICO plc (LON:IXI)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 8.28 and traded as low as GBX 7.50. IXICO shares last traded at GBX 7.50, with a volume of 10,000 shares traded.

IXICO Stock Down 6.2%

The firm has a market capitalization of £16.42 million, a PE ratio of -3.85, a price-to-earnings-growth ratio of -0.38 and a beta of 0.13. The firm’s 50-day moving average is GBX 8.37 and its 200 day moving average is GBX 8.28. The company has a debt-to-equity ratio of 5.22, a quick ratio of 4.90 and a current ratio of 2.83.

IXICO (LON:IXI) last posted its earnings results on Tuesday, May 19th. The company reported GBX (1.21) earnings per share for the quarter. IXICO had a negative net margin of 24.98% and a negative return on equity of 16.18%. The business had revenue of GBX 395 million for the quarter. As a group, research analysts forecast that IXICO plc will post -289.3584879 earnings per share for the current fiscal year.

Insider Transactions at IXICO

In related news, insider Mark Warne bought 50,006 shares of the stock in a transaction on Wednesday, July 15th. The shares were purchased at an average price of GBX 8 per share, for a total transaction of £4,000.48. Insiders own 3.07% of the company’s stock.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.